Case Report Summary: Pancolitis (Ulcerative Colitis) Treated with coMra Therapy

Patient Profile

• Age: 47 years old
• Gender: Male
• Diagnosis: Ulcerative Colitis (1990), progressed to Pancolitis (2014)

Initial Symptoms

• Severe abdominal pain and cramps during relapses (8-10/10 pain scale)
• 12-14 stools of diarrhea per day during relapses
• 3-4 relapses per year
• Blood and mucus in stool (during relapses and >8 stools/day)
• Fatigue and weight loss during relapses

coMra Treatment Protocol

• Device: 980 nm Delta (home user version)
• Initial course: Twice daily for 20 days
• Subsequent treatments: Modified and reduced with therapist cooperation

Additional Therapies

• Pharmacotherapy (anti-inflammatories for colon)
• Before coMra: 5-6 pills daily + suppositories
• After coMra: 2 pills daily, no suppositories

Treatment Outcomes

Fecal Calprotectin Test Results

• Sep 2013: 312 (positive for ulcerative colitis)
• Start of care: Borderline
• Feb 2016 to present: Negative for ulcerative colitis

Symptom Improvements

1. Bowel movements: from 5 per day (diarrhea) to 1 per day (well-formed)
2. No relapses, pain, or cramps since start of care
3. Significant decrease in medication use
4. No dietary restrictions (except milk)

Patient Testimonial (Miroslav Širáň)

• Decreased number of ulcers
• Reduced abdominal pain
• Significant reduction in number of stools
• Medication reduced by one-third
• Improved quality of life
• No special dietary measures required (except avoiding milk)
• Recommends coMra therapy based on personal experience

Conclusion

This case report demonstrates the potential effectiveness of coMra therapy in managing ulcerative colitis, showing significant improvements in symptoms, quality of life, and reduction in medication use.